Switzerland startup funding in H2 2019
European tech funding raised by Switzerland startups during H2 2019.
In H2 2019, 64 startups in Switzerland closed 64 funding rounds and raised €699M in equity funding (excluding debt and grants), up 21.2% versus H2 2018. Debt rounds added €3.6M. Healthtech was the most active sector, and Swisscom Ventures was the most active investor. Data as of 20 Nov 2026.
Equity funding
€699M
+21.2% vs H2 2018 · excl. debt & grants · +€3.6M debt
Funding rounds
64
+36.2% vs H2 2018
Companies
64
Top sector
Healthtech
Rank in Europe
#6
4.1% of European funding
Debt financing
€3.6M
0.5% of total
Top-10 round share
67.1%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthSwitzerland — funding by month, H2 2019 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €281M | 13 |
| Oct | €424M | 51 |
Top sectors
by € raisedSwitzerland — top sectors by capital, H2 2019 — interactive chart.
Data table
| Switzerland — top sectors by capital, H2 2019 | |
|---|---|
| Healthtech | €139M |
| Cybersecurity | €129M |
| Software | €128M |
| Energy | €97M |
| Semiconductors | €68M |
| Fintech | €52M |
| HRtech | €29M |
| Cleantech | €24M |
Stage mix
by € raisedSwitzerland — stage mix, H2 2019 — interactive chart.
Data table
| Switzerland — stage mix, H2 2019 | |
|---|---|
| Series B | €261M |
| Other | €221M |
| Series C | €102M |
| Series A | €54M |
| Seed | €34M |
| Series D+ | €27M |
| Debt | €3.6M |
| Grant | €2.4M |
Exits & M&A
5 Acquisition5 exits · €331M disclosed.
| Amal Therapeutics | Acquisition | Nov 2019 | €325M |
| id4 | Acquisition | Dec 2019 | €6.4M |
Top deals
largest disclosed rounds in H2 2019| Company | Stage | Date | Amount |
|---|---|---|---|
| Acronis | Other | Jul 2019 | €129M |
| Energy Vault | Series B | Jul 2019 | €97M |
| Kandou | Series C | Oct 2019 | €51M |
| Beekeeper | Series B | Oct 2019 | €41M |
| anokion | Series B | Oct 2019 | €37M |
| Numbrs | Other | Oct 2019 | €37M |
| Coople | Series C | Oct 2019 | €29M |
| cellestia biotech | Series B | Oct 2019 | €18M |
| Swissto12 | Series B | Oct 2019 | €17M |
| teralytics | Series D+ | Oct 2019 | €16M |
| Immunos Therapeutics | Series A | Oct 2019 | €14M |
| BC Platforms | Series C | Oct 2019 | €14M |
| Avrios | Series B | Oct 2019 | €13M |
| L.E.S.S. | Series B | Jul 2019 | €13M |
| Kuros Biosciences | Other | Oct 2019 | €12M |
Top investors
most active in H2 2019, by deal count- Swisscom Ventures2 deals
- Swisscanto Invest2 deals
- AM Ventures1 deals
- Armada Investment Group1 deals
- Beat Curti1 deals
- Bernina BioInvest1 deals
- Bessemer Venture Partners1 deals
- BioMedPartners1 deals
- Blue Horizon Corporation1 deals
- Blufolio1 deals